NASDAQ Stock Movers on Equity Offerings: BCOM, NEXM, GLUU, GILD

Shares of B Communications Ltd. (NASDAQ:BCOM) rose 4.60% to $22.10 after  today the company filed a mixed shelf with the Israeli Securities Authority and the Tel Aviv Stock Exchange.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.pennystockpickreport.com/

Equities and debt filed for sale include ordinary shares, debt securities, debt securities convertible into ordinary shares, warrants to purchase ordinary shares, debt securities and commercial paper.

NexMed, Inc. (NASDAQ:NEXM) shares rose 2.55% to $2.01 after it filed a registration with the U.S. Securities and Exchange Commission today to sell, from time to time, up to $6.5 million of Units, each of which consists of one share of Common Stock and one warrant.

Dawson James Securities will be lead book runner on the offering.

NexMed, Inc. focuses on research and development in the area of drug delivery. Its drug delivery technology is called NexACT. The Company has two operating segments: designing and developing pharmaceutical products (The NexACT drug delivery technology business) and providing pre-clinical CRO services.

Glu Mobile Inc. (NASDAQ:GLUU) shares rose 3.54% to $1.17 it filed a registration with the U.S. Securities and Exchange Commission today to sell, from time to time, up to 20,242,500 shares of Common Stock on behalf of Selling Shareholders.

Glu Mobile Inc. (Glu Mobile) is engaged in designing, marketing and selling games for mobile phones. The Company has developed and published a portfolio of casual and traditional games designed to appeal to a cross section of the subscribers served by its wireless carriers and other distributors, as well as to users of smartphones who purchase the Company’s games through direct-to-consumer digital storefronts.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.pennystockpickreport.com/

Gilead Sciences, Inc. (NASDAQ:GILD) rose marginally to $2.04 to $32.48 after it nnounces that they have repurchased approximately $2.2 billion of common stock under previously announced $5 billion stock buyback program.

In conjunction with the company’s announcement of its convertible debt offering on July 26, 2010, Gilead has since acquired approximately $1.0 billion of shares repurchased at an average price of $33.68. Purchase activity in the third quarter to date is approximately $1.4 billion in common stock.

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. The Company has operations in North America, Europe and Australia.

About http://www.pennystockpickreport.com/

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.